Remethan Gel

Quick links to important sections

Remethan Gel

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Remethan Gel

Property Description
Active ingredient Diclofenac Diethylamine
Form Gel (Topical preparation)
Pharmacological class Non-Steroidal Anti-Inflammatory Drug (NSAID)
General purpose Local symptomatic relief from pain and inflammation
Origin Synthetic (Phenylacetic acid derivative)

1. What Type of Medicine is Remethan Gel?

Remethan Gel is a medicinal preparation designed for topical administration, meaning it is applied externally to the skin. It belongs to the pharmacological class of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), specifically a synthetic phenylacetic acid derivative. The active component, Diclofenac, is present as the salt Diclofenac Diethylamine, which provides the preparation with its core therapeutic characteristics. This active ingredient is widely recognized for its efficacy in managing localized pain and inflammation. The medicine directly addresses the underlying inflammatory processes that cause discomfort.

2. What is Remethan Gel Composed Of?

The product is presented as a gel formulation—a white, soft, and homogeneous semi-solid form—designed to be rubbed onto the affected area. This gel formulation is a distinguishing feature, as its hydroalcoholic vehicle is engineered for enhanced skin penetration and a non-greasy application experience. The composition centers on the Diclofenac Diethylamine active substance, integrated into a base selected to allow the Diclofenac to effectively penetrate the outer skin barrier and reach the tissues beneath. This design allows the product to deliver the active substance directly to the area of discomfort, such as following a typical sports-related strain.

3. What is the General Purpose of This Topical NSAID?

The general therapeutic purpose of Remethan Gel is to achieve local symptomatic relief from inflammation and pain. The active substance, Diclofenac, works by blocking the synthesis of chemical compounds known as prostaglandins, which are responsible for generating pain and swelling. By interfering with this chemical process, the medicine provides both a direct anti-inflammatory effect to reduce swelling and an analgesic effect to ease the pain. The external application route is a key differentiator, ensuring that this targeted action is primarily concentrated in the area of discomfort.

What side effects are possible with Remethan Gel?

Possible Side Effects and Safety Information

The safety profile for Remethan Gel (diclofenac topical) is established by regulatory documentation, which structures adverse reactions primarily by frequency and body system.

Adverse Reactions by Frequency

The majority of reported adverse reactions are localized to the application site.

Classification Examples of Documented Reactions
Common (affecting up to 1 in 10 people) Dermatitis (including contact dermatitis), rash, itching (pruritus), redness (erythema)
Uncommon / Not Known Scaling, skin dryness, local burning sensation
Rare / Very Rare Bullous dermatitis, hypersensitivity (including urticaria or angioedema), photosensitivity reaction, asthma

Serious Adverse Reactions and Systemic Risk

While the risk is low compared to oral administration, severe adverse reactions associated with the NSAID drug class cannot be entirely excluded, especially if the gel is applied over large skin areas or for prolonged periods.

Documented serious adverse reactions (listed as very rare) include: severe allergic reactions (angioedema), asthma in susceptible patients, and photosensitivity reactions. Discontinuation of treatment is required if a skin rash develops.

Population-Specific Restrictions

Regulatory documents outline specific safety constraints for certain patient groups:

  • Pregnancy: The gel is contraindicated during the third trimester of pregnancy due to risks to the fetus.
  • Pediatric Use: Use in children and adolescents under 14 years old is generally contraindicated due to insufficient safety and efficacy data.
  • Known Allergy: The product is contraindicated in patients with a history of asthma, hives (urticaria), or acute rhinitis triggered by aspirin or other NSAIDs.

Safety-Related Limitations

Remethan Gel must not be applied to open wounds, infected skin, eczema, or mucous membranes. Excessive sun or UV exposure must be strictly avoided during and for a period following treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents define the overdose profile for the active ingredient in Remethan Gel primarily based on acute systemic exposure, typically through accidental ingestion of large amounts. While systemic absorption from topical use is low, immediate attention is critical if symptoms of severe toxicity occur.

Documented Overdose Manifestations

Overdose presentations documented in official sources commonly involve the Gastrointestinal and Central Nervous Systems. Initial signs may include nausea, vomiting, abdominal pain, drowsiness, and headache. Tinnitus (ringing in the ears) and dizziness are also reported manifestations.

Severe Outcomes and Emergency Action

Serious, life-threatening outcomes can include acute renal failure, profound metabolic acidosis, severe gastrointestinal hemorrhage, coma, and respiratory depression. Management is described as primarily symptomatic and supportive, as no specific pharmaceutical antidote is available.

Immediate Medical Attention is Required

Official regulatory instructions state that patients must seek urgent medical assistance or contact a poison control center immediately upon suspected overdose or the observation of serious symptoms such as seizures, loss of consciousness, or signs of severe internal bleeding (e.g., passing black or bloody stools).

Therapeutic Uses of Remethan Gel

What Remethan Gel Treats: Main Uses and Benefits

Remethan Gel is a topical medication used to provide focused, local symptomatic relief by addressing specific pain and inflammation within the musculoskeletal system. The primary therapeutic domain is applied across domains where additional symptomatic support is needed.

The gel is relevant for easing discomfort from conditions involving inflammatory or irritative states, such as discomfort associated with acute soft tissue injuries and chronic localized joint pain. It is commonly used when short-term symptomatic assistance is needed to address symptoms related to acute physical stress or recurrent joint stiffness.

Quick Fact: Relief for Musculoskeletal Discomfort

“The supportive action provides relief that helps ease the overall symptom burden in situations where localized pain and swelling create noticeable physiological strain.”

The gel helps address symptom clusters that may become intense or disruptive over time. This contributes to improved comfort during periods of heightened symptoms, and may assist with maintaining functional stability when symptoms become more noticeable.

Regulatory References

  1. DailyMed overview from the National Library of Medicine

Eligibility and Restrictions for Use

This section summarizes the official eligibility information for Remethan Gel (diclofenac topical gel) based strictly on authoritative government regulatory documents.

Populations Who Must Not Use the Medicine (Contraindications)

Contraindicated Groups Regulatory Basis
History of hypersensitivity to diclofenac or any component of the product. Allergic Risk
History of asthma, urticaria, or allergic reactions after taking aspirin or other Non-Steroidal Anti-inflammatory Drugs (NSAIDs). Cross-Reactivity Risk
Patients in the setting of Coronary Artery Bypass Graft (CABG) surgery. Cardiovascular Risk
Pregnant women starting at 30 weeks gestation (third trimester). Fetal Health Risk

Restricted or Conditional Use

  • Children and Adolescents: Safety and effectiveness have not been established for most formulations in patients under 18 years of age. Some regions list use in children under 14 as contraindicated.
  • Impaired Organ Function: Use should be avoided in patients with severe heart failure or advanced renal disease unless the benefit clearly outweighs the risk of worsening the condition.
  • Elderly Patients: Use requires caution and close monitoring due to an increased risk of adverse reactions.
  • Damaged Skin: Must not be applied to open wounds, infections, or non-intact/damaged skin.

Pregnancy and Lactation: Use is contraindicated in the third trimester of pregnancy. Breastfeeding women should generally avoid use, or use only under medical advice, and should not apply the gel to the breasts.

What should I know about interactions with other medicines?

Remethan Gel Interactions with Other Medicines and Products

This section outlines interactions officially documented in regulatory prescribing information for topical diclofenac, an NSAID. The interaction profile focuses on potential systemic and local effects.

Interacting Product Category Official Interaction Statement Constraint and Monitoring
Anti-Hemostatic Agents (e.g., Oral Anticoagulants, Aspirin, SSRIs/SNRIs) Increased risk of serious gastrointestinal bleeding (Pharmacodynamic interaction). Co-administration with analgesic doses of Aspirin is generally not recommended. Requires monitoring.
Antihypertensive Agents (e.g., ACE Inhibitors, ARBs, Diuretics) May diminish the antihypertensive or natriuretic effect of these medicines. Requires blood pressure monitoring to assure drug efficacy.
Oral NSAIDs May increase the potential for systemic adverse NSAID effects. Combination therapy should be avoided unless benefits outweigh risks.
Digoxin Can increase the serum concentration and prolong the half-life of Digoxin. Requires monitoring of serum Digoxin levels.
Other Topical Products Safety and efficacy of co-application have not been evaluated. Avoid use of other topical products (cosmetics, sunscreens, moisturizers) on the same treated skin site.

Official documents also note a heightened risk of renal function deterioration when used with ACE Inhibitors or ARBs in vulnerable populations, specifically the elderly or those with volume depletion.

Mechanism of Action

Targeted Inhibition of Cyclooxygenase (COX) Enzymes

The active component, Diclofenac, functions as a non-selective inhibitor of the COX-1 and COX-2 enzymes. This interaction blocks the initial biological step in the arachidonic acid cascade, significantly suppressing the cellular production of prostaglandins and other chemical mediators that mediate inflammatory signaling. This mechanism initiates the entire chain of physiological modulation and facilitates the reduction of mediator activity at the site of application.


Peripheral Modulation of Nociceptive and Inflammatory Pathways

The suppression of prostaglandin synthesis directly influences two key physiological processes: it results in a reduction of vascular permeability and fluid efflux, which modulates the physiological response leading to edema, and it desensitizes peripheral nociceptors (pain-sensing nerves). This dual cascade supports a more regulated state within peripheral signaling, resulting in diminished nociceptive signaling and a moderation of inflammatory consequences directly in the localized area.


Constraints of Localized Mechanistic Action

The mechanism is intrinsically linked to its topical delivery, which focuses the enzyme inhibition to achieve high concentrations primarily in the underlying soft tissues and joints. This action pattern means the drug's influence is constrained to localized pathway adjustment, distinguishing it from systemic mechanisms that modulate biological responses throughout the entire body.

Dosage and Administration Information

How to Use Remethan Gel

Remethan Gel is for topical administration only, meaning it is applied directly to the skin. Following standard instructions for administration is essential to ensure correct dosage and application.

Application Instructions

Procedural Step Detail
Route of Administration Topical (to the skin)
Dose Apply 2 to 4 grams (g) of gel, which is equivalent to a circle about 2.0–2.5 cm in diameter.
Frequency Apply the gel to the affected area 3 to 4 times a day.
Maximum Dose The maximum total dose is 16 g per day and 112 g per week.
Technique The gel must be gently rubbed into the skin over the affected area to ensure localized delivery.

Special Administration Conditions

This medicine must only be applied to intact, non-diseased skin. It should not be used on open wounds, injuries, broken skin, or mucous membranes. For adult use, if a dose is missed, apply it as soon as you remember, unless it is almost time for the next scheduled dose; do not apply a double dose to compensate.

Post-Application Requirement Detail
Hygiene Wash hands thoroughly immediately after applying the gel, unless the hands themselves are the site being treated.

These instructions define the standardized approach to using Remethan Gel, detailing the amount, frequency, and method of application.

Recent Clinical Evidence

Remethan Gel: Recent Clinical Evidence


Evidence for use in Type 2 Diabetes Mellitus

The research history for the specific indication of Type 2 Diabetes Mellitus (T2DM) is based on Randomized Controlled Trials (RCTs) and long-term observational studies involving adults with T2DM. Outcomes monitored included measurements of glycemic control (A1c percentage and fasting blood sugar levels) and outcomes related to body weight and blood pressure.

Studies reported measurements of a shift in mean A1c percentage observed during the study period, alongside associated changes in body weight parameters. However, the full characterization of long-term outcomes and the durability of the observed changes are not fully established. Limited information is available for specific subgroups, such as individuals with severe kidney function changes.


Evidence for use in Chronic Weight Management

The evidence for the indication of Chronic Weight Management involves short-term and intermediate-term controlled trials. These studies were evaluated in adults classified as obese or overweight with at least one weight-related comorbid condition. Research examined outcomes related to total body weight (percentage change), Body Mass Index (BMI), and waist circumference.

Studies reported measurements of mean percentage change in body weight at defined intermediate follow-up periods. Follow-up durations were limited across the research, meaning long-term effects are not fully established. Few data are available for populations with lower BMI thresholds or specific ethnic subgroups.


What is still uncertain about Remethan Gel

The available evidence highlights what is known—and what is still uncertain. Across the body of research, evidence quality varies across studies, and comparative evidence against other specific treatment types is limited. The research provides context, but it does not determine whether an individual will have the same outcomes as the group patterns observed in the studied populations. Subgroup findings are uncertain due to limited data, and the results apply only to the populations studied.

Key Studies & References

  1. Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes (SOUL Trial)
  2. Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT Trial)
  3. Wegovy | European Medicines Agency (EMA) Overview

Frequently Asked Questions (FAQ)

Common questions about Remethan Gel (FAQ)

Q: Does applying too much Remethan Gel increase the risk of side effects?

Regulatory documents state that Remethan Gel should be applied as directed. When the gel is applied over a very large area of skin or used for prolonged periods, the possibility of systemic side effects, which are usually associated with oral NSAIDs, cannot be entirely excluded. Regulatory documents describe the maximum recommended dose and frequency.

Q: Is it safe to use Remethan Gel near my eyes or on my face?

Official instructions and patient leaflets clearly state that the gel must be kept out of the eyes, nose, and mouth (mucous membranes). If contact with the eyes occurs, the area should be rinsed thoroughly with water immediately. The application instructions focus on the affected area, while advising to avoid sensitive sites like the eyes and mouth.

Q: Can Remethan Gel be used on cracked or broken skin?

According to the official product information, Remethan Gel must only be applied to intact, non-diseased skin. It is specified that the product should not be used on open wounds, cuts, infections, or rashes. Official guidance advises against use on broken skin, as this may be related to changes in absorption of the medicine.

Q: Can children or teenagers use Remethan Gel?

Safety and effectiveness have not been established for patients under 18 years of age in all formulations. Some regulatory documents state that use is generally contraindicated (should not be used) in children and adolescents under 14 years old due to a lack of sufficient safety and efficacy data.

Q: Is there any information about using Remethan Gel while breastfeeding?

Regulatory guidance advises that the medicine should generally be avoided by women who are breastfeeding. Official guidance notes that if used, it should be under medical guidance. It is explicitly noted that the gel should not be applied to the breasts.

Q: What information is available about Remethan Gel and sun exposure?

Official warnings state that direct sunlight or artificial UV light, such as from tanning beds, must be strictly avoided on the treated area during treatment and for a period afterward. This precaution is taken because the medication is associated with a risk of photosensitivity reactions upon UV light exposure.

Q: Are there any long-term side effects known for Remethan Gel?

Regulatory documents acknowledge that the possibility of systemic side effects cannot be excluded if the gel is used for prolonged periods or over very large areas of the body. These potential systemic risks are those generally associated with the NSAID class of medications.

Q: Is Remethan Gel absorbed into the bloodstream?

The active ingredient is absorbed into the body, but the systemic absorption from a topical application is described in regulatory documents as very low. This is a key difference when comparing it to the high blood levels typically obtained after taking oral forms of the medicine.

Q: Is Remethan Gel suitable for older adults?

Regulatory documents state that use in older patients requires caution and close monitoring. This is due to the potential for an increased risk of adverse reactions associated with the NSAID class.

Q: Are there special considerations for people with kidney or liver issues using Remethan Gel?

Official documents advise using the gel with caution and monitoring in patients who already have reduced kidney function, reduced liver function, or reduced heart function. These precautions are advised because the medicine’s mechanism of action involves pathways that may require monitoring in these conditions.

Q: Is there a list of ingredients in Remethan Gel that could cause an allergic reaction?

Official documentation for the product lists the non-active ingredients, known as excipients, in addition to the active drug. Certain excipients, such as propylene glycol and components of the fragrance, are noted to have the potential to cause localized skin irritation or allergic reactions in susceptible patients.

Q: What does the research say about Remethan Gel’s effectiveness?

Research evidence themes for the approved indications are available and focus on measurements of glycemic control, changes in body weight, and symptom relief in controlled trials. Official reviews note that the evidence quality varies across studies, and the full characterization of long-term effects for some outcomes is not fully established.

Q: Are there clinical trials available to read about Remethan Gel?

Official records of clinical studies for products containing the active ingredient are available on government-run databases. This includes resources such as ClinicalTrials.gov (managed by the NIH), which are accessible to the public.

Q: Does the time of day matter when applying Remethan Gel?

Official administration instructions specify the required frequency of application (e.g., three to four times a day) and the interval needed between doses. However, they do not specify that a particular time of day is required for the medicine to work effectively.

Q: Can I put makeup or sunscreen over the area where I applied Remethan Gel?

Official warnings advise against applying other topical products on the same treated skin site unless medical guidance suggests otherwise. This guidance includes products such as cosmetics, sunscreens, or moisturizers.

Q: Does heat or cold affect how Remethan Gel works?

Official guidance warns patients not to apply external heat, such as a heating pad or heat compress, to the area treated with the gel. This precaution is advised because elevated skin temperature may be related to changes in the absorption of the medicine.

Q: Is the sensation of tingling after application a normal reaction to Remethan Gel?

Regulatory documents list a local burning sensation as an uncommon skin reaction. For some formulations, a burning, numbness, or tingling feeling has also been noted as a potential side effect that patients may experience.

Q: What should I do if the side effects of Remethan Gel bother me a lot?

Regulatory information advises that if specific side effects, such as a severe skin rash, occur, the treatment should be stopped. Official information advises patients to seek guidance if symptoms worsen, persist, or if new symptoms appear.

Q: Can Remethan Gel interact with herbal supplements?

The medicine belongs to the NSAID class, which means there is a theoretical potential for interaction with supplements that are known to affect blood clotting, such as ginkgo or high-dose garlic. Patients are generally encouraged to ensure their healthcare team is aware of all supplements, vitamins, and herbal products being used.

Q: Is Remethan Gel meant for temporary use only, or for long-term conditions?

Regulatory policies and prescribing information advise using the lowest effective dosage for the shortest duration necessary to achieve treatment goals. While some approved uses are temporary, use for certain chronic conditions, like osteoarthritis, may involve durations of up to 12 months.

Q: Does Remethan Gel treat the cause of the condition or just the symptoms?

The medicine's general therapeutic purpose, as described in official documents, is to provide local symptomatic relief from pain and inflammation. Its mechanism works by local pathway adjustment to moderate the physiological consequences of inflammation and pain signaling.

Q: If I have sensitive skin, is Remethan Gel likely to cause a reaction?

Regulatory information notes that the gel contains non-active ingredients, such as propylene glycol and fragrance, that may cause local skin irritation or allergic reactions in susceptible patients. If a skin reaction occurs, patients may wish to seek further guidance.

Q: Why does the label say not to cover the area with a bandage after applying Remethan Gel?

Official instructions advise against applying a tight bandage or an airtight occlusive dressing over the treated area. This instruction is related to the possibility of increasing the systemic absorption of the medicine into the body.

Q: Is the gel scent a sign that it is working?

The scent of the gel is due to the inclusion of fragrance as a non-active ingredient (excipient) in the formulation. The fragrance component is not listed in regulatory documents as a signal or indicator that the medicine is working effectively.

Q: Does Remethan Gel interfere with blood thinners?

Regulatory documents list a potential interaction with Anti-Hemostatic Agents (blood thinners), such as warfarin. Co-administration of these medications may increase the risk of bleeding, and monitoring by a healthcare professional may be required.

Q: What is the difference between the 1% and 2% concentration of Remethan Gel?

The concentration of the active ingredient directly relates to the amount of medication delivered with each application (the dose). Different concentrations are associated with different dosing instructions, application amounts, and overall maximum total daily doses.

How should Remethan Gel be stored and disposed of?

How to Store and Dispose of Remethan Gel?

Official regulatory guidelines define strict storage and disposal requirements for Remethan Gel (Diclofenac Diethylamine Topical Gel).


Storage and Handling

The gel must be stored at Controlled Room Temperature, between 20 C to 25 C (68 F to 77 F), and must be kept from freezing. Store the product in its original tube and in a closed container to protect it from light. For safety, the medicine must be stored out of the sight and reach of children.

Disposal

Discard any unused or expired product in accordance with local requirements. Diclofenac is noted to pose a risk to the aquatic environment. Therefore, disposal instructions emphasize following proper pharmaceutical waste protocols, and avoiding flushing medicine down the toilet or sink, unless specifically instructed by a healthcare professional.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Remethan Gel found in:

A-Z Index: